Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer

25 Jan 2023

Abstract excerpt

Background: Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) has been reported to exhibit an oncogenic effect as an RNA-binding protein (RBP) by promoting tumor cell proliferation, migration and invasion in several tumor types. However, a pan-cancer analysis of IGF2BP3 is not currently available, and the exact roles of IGF2BP3 in prognosis and immunology in cancer patients remain enigmatic. The main...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36761737
DOI: 10.3389/fimmu.2023.1071675

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancerPMID 36761737Read ↗

IGF2BP3 expression in pan-cancer: A bioinformatics-based study of its prognostic relevance and immunological roleSemantic proximity Read ↗

A Pan-Cancer Analysis of the Oncogenic Role of Insulin-Like Growth Factor2 mRNA -Binding Protein 2 (IGF2BP2) in Human TumorsSemantic proximity Read ↗

IGF2BP3 promotes progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent mechanismSemantic proximity Read ↗

RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferationSemantic proximity Read ↗

The pan-cancer landscape of RNA-binding protein MEX3A: A prognostic and immunological biomarker validated in gastric cancerSemantic proximity Read ↗

Prognostic and Immunological Characterization of NSD3 Evaluated Through an Integrative Pan-Cancer AnalysisSemantic proximity Read ↗

Comprehensive analysis of long non-coding RNA MAGI2-AS3 as a key immune regulator, therapeutic target and prognostic biomarker across pan-cancer with a focus on colorectal cancerSemantic proximity Read ↗

IGF2BP3 Associates with Proliferative Phenotype and Prognostic Features in B-Cell Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancerSemantic proximity Read ↗

The m6A reader IGF2BP3 Facilitates Gastric Cancer Progression Through Activating EMT via Upregulating MYC mRNA StabilitySemantic proximity Read ↗

APOBEC3C Served as a Novel Immune-Related Prognosis Biomarker in Glioma: A Pan-Cancer AnalysisSemantic proximity Read ↗

RNA N6-methyladenosine Reader IGF2BP2 Promotes Lymphatic Metastasis and Epithelial-mesenchymal Transition of Head and Neck Squamous Carcinoma Cells via Stabilizing Slug mRNA in an M6A-dependent MannerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.